- CLINICAL BRIEFINGS
Through comprehensive genomic and immune analyses, mechanisms of lung cancer resistance after treatment with EGFR inhibition and vaccine therapy were investigated. This case report, together with data from the longitudinal lung cancer study TRACERx, highlight the importance of understanding when targeted variants are acquired during the cancer’s evolutionary history.
Why labs need a napping room to help you work, rest and play
Holly Newson 00:00 Welcome to Working Scientist, a Nature Careers podcast. I’m Holly Newson, and in this series, you’ll hear...
Forty-five years of progress after a key paper about the evolution of cooperation
Axelrod, R. & Hamilton, W. D. Science 211, 1390–1396 (1981).Article PubMed Google Scholar Maynard Smith, J. & Price, G. R....
I paused my PhD for 11 years to help save Madagascar’s seas
Ando Rabearisoa worked with local fishers to establish locally managed marine conservation areas that protect fisheries and local incomes in...
AI is programmed to hijack human empathy — we must resist that
Log on to Moltbook, a social network for artificial-intelligence agents, and you might see one bot lamenting its ‘embarrassing’ habit...
